ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,000 | -63.0% | 15,064 | -55.5% | 0.00% | – |
| Q3 2021 | $73,000 | -22.3% | 33,825 | +26.2% | 0.00% | – |
| Q2 2021 | $94,000 | -66.4% | 26,807 | +3.8% | 0.00% | -100.0% |
| Q4 2020 | $280,000 | -70.5% | 25,819 | -71.9% | 0.00% | -84.6% |
| Q3 2020 | $948,000 | -26.5% | 92,037 | -17.8% | 0.01% | +62.5% |
| Q4 2019 | $1,290,000 | +17.9% | 111,971 | -44.2% | 0.01% | -20.0% |
| Q3 2019 | $1,094,000 | +559.0% | 200,668 | +1333.3% | 0.01% | +400.0% |
| Q2 2019 | $166,000 | -3.5% | 14,000 | -52.8% | 0.00% | -33.3% |
| Q1 2018 | $172,000 | +48.3% | 29,642 | -6.8% | 0.00% | +50.0% |
| Q3 2017 | $116,000 | +346.2% | 31,800 | +208.6% | 0.00% | +100.0% |
| Q2 2017 | $26,000 | -7.1% | 10,303 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $28,000 | – | 10,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |